Biotage Makes a Change in Top Management after Business Area President Resigns
News Feb 28, 2006
Biotage has announced the change in its top management. David Patteson, President of the business area Discovery Chemistry has decided to seek new challenges elsewhere. He will leave the company on 1 April 2006.
David Patteson has been with Biotage for seven years during which time he has successfully built up the Global operations. In the last years he also led the integration of the acquired companies and the cost reductions that followed.
The forthcoming CEO of Biotage, Torben Jorgensen, will take over Mr Patteson's responsibilities with immediate effect and work alongside him until 1 April.
PhoreMost Completes $15M (£11M) Series-A Round to Enter Drug DiscoveryNews
Investment to fund expansion of operations and progression of drug target pipeline.READ MORE
Abzena Selects Sartorius Stedim Biotech to Equip its US Based Development and Manufacturing SitesNews
Abzena plc, the life sciences group providing services and technologies to enable the development and manufacture of biopharmaceutical products, has selected Sartorius Stedim Biotech as its preferred equipment supplier in the U.S.READ MORE
Molecule Prevents Common Cold Virus from Hijacking Human CellsNews
Researchers have lab-tested a molecule that can combat the common cold virus by preventing it from hijacking human cells.READ MORE
Comments | 0 ADD COMMENT
International Conference on Biobetters and Regulatory Affairs
Jun 27 - Jun 28, 2018
9th International Conference on Mass Spectrometry and Chromatography
Sep 21 - Sep 22, 2018